Pioneering cannabinoid-based therapeutics
Tetra Bio-Pharma (tetrabiopharma.com) earns a Brand Analyzer score of 46 out of 100, placing it in the Early Stage tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Tetra Bio-Pharma ranks in the 2nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 82/100, Digital Presence 71/100, Visual Identity 0/100, Messaging Clarity 95/100, Trust Foundation 39/100, AI Discoverability 35/100, Brand Authority 9/100.
Tetra Bio-Pharma is a biopharmaceutical company focused on developing cannabinoid-based medicines to address unmet medical needs in pain management and chronic diseases. The company combines pharmaceutical expertise with cannabinoid science to deliver clinically validated, regulatory-approved therapies. Its pipeline targets evidence-based treatments for severe pain and neurological conditions, serving healthcare professionals, patients, and pharmaceutical investors.
| Brand Name | Tetra Bio-Pharma |
|---|---|
| Domain | tetrabiopharma.com |
| Industry | Healthcare, Technology |
| Main Competitors | GW Pharmaceuticals (Jazz Pharmaceuticals), Tilray Brands, Canopy Growth, Arena Pharmaceuticals, Zynerba Pharmaceuticals, Cardiol Therapeutics |
Moz Domain Authority 39/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Tetra Bio-Pharma develops innovative cannabinoid-based medicines to address unmet medical needs in pain management and chronic diseases." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Facebook, Instagram; no detected presence on X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Tetra Bio-Pharma scores 19/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Tetra Bio-Pharma has a weak AI-visibility profile at 19/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 39/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Tetra Bio-Pharma's main competitors include GW Pharmaceuticals (Jazz Pharmaceuticals), Tilray Brands, Canopy Growth, Arena Pharmaceuticals, Zynerba Pharmaceuticals. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Tetra Bio-Pharma official site
Popular alternatives to Tetra Bio-Pharma include GW Pharmaceuticals (Jazz Pharmaceuticals), Tilray Brands, Canopy Growth, Arena Pharmaceuticals, Zynerba Pharmaceuticals. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Tetra Bio-Pharma official site
Tetra Bio-Pharma has low AI-search visibility, scoring 19/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 22, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Tetra Bio-Pharma official site
Tetra Bio-Pharma is a biopharmaceutical company that develops innovative cannabinoid-based medicines. It is positioned as a leading biopharmaceutical innovator in cannabinoid therapeutics, combining pharmaceutical expertise with cannabinoid science. The company focuses on delivering clinically validated and regulatory-approved therapies targeting severe pain and neurological conditions, addressing unmet medical needs in pain management and chronic diseases.
Sources: Tetra Bio-Pharma official site
Tetra Bio-Pharma and GW Pharmaceuticals (Jazz Pharmaceuticals) are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Tetra Bio-Pharma official site
Tetra Bio-Pharma scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Tetra Bio-Pharma official site
Tetra Bio-Pharma can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Tetra Bio-Pharma official site
Tetra Bio-Pharma's target audience includes healthcare professionals who may prescribe or recommend cannabinoid-based therapies, patients suffering from chronic pain and neurological disorders who seek alternative or specialized treatment options, and pharmaceutical investors interested in cannabinoid innovations. The company's focus on regulatory approval and clinical validation suggests its products are intended for use within formal healthcare settings.
Sources: Tetra Bio-Pharma official site
Tetra Bio-Pharma is known for its focus on developing clinically validated, regulatory-approved cannabinoid-based medicines. The company is recognized for combining pharmaceutical-grade rigor with cannabinoid science, and for targeting evidence-based treatments for severe pain and neurological conditions. It is positioned as a leading innovator in cannabinoid therapeutics within the biopharmaceutical sector.
Sources: Tetra Bio-Pharma official site
Ranked closest to Tetra Bio-Pharma: SOPEO NOW (46/100), Nippon Shinyaku Co., Ltd. (46/100), Imagenet (45/100), ICICI Prudential Life Insurance (45/100).
A step up - brands to learn from: Werskincare (56/100), Virtue TCM 醫道閣 (56/100).
Category leader: Dassault Systèmes (95/100).